Literature DB >> 6791804

The Whipple procedure and other standard operative approaches to pancreatic cancer.

W P Longmire, L W Traverso.   

Abstract

In a series of 50 patients with cancer of the pancreas who wee undergoing resection of the pancreatic head and the duodenum, the average survival was 16.2 months. If the resected margin was free of tumor the average survival was 20.3 months. In 103 less favourable cases treated by biliary bypass, with or without gastroenterostomy, the average survival was only 6.2 months. Although these series are not comparable, pancreaticoduodenal resection for cancer of the pancreas and periampullary area has been utilized in cases without distant metastases in an effort to extend the period of palliation and to achieve occasional long-term survival. Currently available diagnostic techniques may permit earlier diagnosis and improved results. A positive tissue diagnosis is not essential before proceeding with resection, but this aspect of the operation should be fully discussed with the patient. An unfavorable condition of the residual pancreas for anastomosis, or a positive frozen section examination of the pancreas at the line of transection may indicate total pancreatectomy, but complete resection is not used routinely. The incidence of jejunal ulceration, a serious late postoperative complication, may be reduced by utilizing a 60-70% gastric resection or antrectomy and vagotomy.

Entities:  

Mesh:

Year:  1981        PMID: 6791804     DOI: 10.1002/1097-0142(19810315)47:6+<1706::aid-cncr2820471441>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

Review 1.  Adjuvant and neoadjuvant therapies of pancreatic cancer: a review.

Authors:  J Harris; H Bruckner
Journal:  Int J Pancreatol       Date:  2001

Review 2.  Pylorus-preserving pancreaticoduodenectomy in the treatment of chronic pancreatitis.

Authors:  Ramon E Jimenez; Carlos Fernandez-Del Castillo; David W Rattner; Andrew L Warshaw
Journal:  World J Surg       Date:  2003-10-13       Impact factor: 3.352

3.  Factors influencing survival after resection for ductal adenocarcinoma of the pancreas.

Authors:  A Mannell; J A van Heerden; L H Weiland; D M Ilstrup
Journal:  Ann Surg       Date:  1986-04       Impact factor: 12.969

4.  Surgery for periampullary and pancreatic carcinoma: a Liverpool experience.

Authors:  A N Kingsnorth
Journal:  Ann R Coll Surg Engl       Date:  1997-07       Impact factor: 1.891

5.  Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results.

Authors:  K E Bakkevold; B Kambestad
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

6.  Comparison of conventional surgical resection, radioactive implantation, and bypass procedures for exocrine carcinoma of the pancreas 1975-1980.

Authors:  M Morrow; B Hilaris; M F Brennan
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

7.  The role of laparoscopy in the management of suspected pancreatic and periampullary malignancies.

Authors:  M D Holzman; K L Reintgen; D S Tyler; T N Pappas
Journal:  J Gastrointest Surg       Date:  1997 May-Jun       Impact factor: 3.452

8.  Failure of new diagnostic aids in improving detection of pancreatic cancer at a resectable stage.

Authors:  V Savarino; C Mansi; L Bistolfi; P Zentilin; G Celle
Journal:  Dig Dis Sci       Date:  1983-12       Impact factor: 3.199

9.  Safety and function of isolated Roux loop pancreaticojejunostomy after Whipple's pancreaticoduodenectomy.

Authors:  A N Kingsnorth
Journal:  Ann R Coll Surg Engl       Date:  1994-05       Impact factor: 1.891

Review 10.  Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayesian network meta-analysis.

Authors:  Victor Hugo Fonseca de Jesus; Rachel P Riechelmann
Journal:  Ecancermedicalscience       Date:  2021-08-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.